{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T23:12:31Z","timestamp":1761520351328,"version":"build-2065373602"},"reference-count":42,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinical-colorectal-cancer.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Colorectal Cancer"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1016\/j.clcc.2023.01.005","type":"journal-article","created":{"date-parts":[[2023,2,5]],"date-time":"2023-02-05T01:20:13Z","timestamp":1675560013000},"page":"167-174","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Patterns of Care for Patients With Locally Advanced Rectal Cancer Treated with Total Neoadjuvant Therapy at Predominately Academic Centers between 2016-2020: An NCDB Analysis"],"prefix":"10.1016","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2287-2320","authenticated-orcid":false,"given":"Jason","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Colton","family":"Ladbury","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Scott","family":"Glaser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marwan","family":"Fakih","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreas M.","family":"Kaiser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi-Jen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Terence M.","family":"Williams","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arya","family":"Amini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.clcc.2023.01.005_bib0001","first-page":"7","article-title":"Cancer statistics, 2022","volume":"72","author":"Siegel","year":"2022","journal-title":"CA Cancer J Clin"},{"issue":"16","key":"10.1016\/j.clcc.2023.01.005_bib0002","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1200\/JCO.2011.40.1836","article-title":"Preoperative versus postoperative chemoradiotherapy for locally advanced rectal cancer: results of the German CAO\/ARO\/AIO-94 randomized phase iii trial after a median follow-up of 11 years","volume":"30","author":"Sauer","year":"2012","journal-title":"J Clin Oncol"},{"issue":"31","key":"10.1016\/j.clcc.2023.01.005_bib0003","doi-asserted-by":"crossref","first-page":"5124","DOI":"10.1200\/JCO.2009.22.0467","article-title":"Preoperative multimodality therapy improves disease-free survival in patients with carcinoma of the rectum: NSABP R-03","volume":"27","author":"Roh","year":"2009","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"issue":"9","key":"10.1016\/j.clcc.2023.01.005_bib0004","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1002\/cncr.30600","article-title":"Total neoadjuvant therapy for rectal cancer: an emerging option","volume":"123","author":"Ludmir","year":"2017","journal-title":"Cancer"},{"issue":"7","key":"10.1016\/j.clcc.2023.01.005_bib0005","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/S1470-2045(12)70187-0","article-title":"Preoperative chemoradiotherapy and postoperative chemotherapy with fluorouracil and oxaliplatin versus fluorouracil alone in locally advanced rectal cancer: initial results of the German CAO\/ARO\/AIO-04 randomised phase 3 trial","volume":"13","author":"R\u00f6del","year":"2012","journal-title":"Lancet Oncol"},{"issue":"2","key":"10.1016\/j.clcc.2023.01.005_bib0006","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1007\/s11605-012-2073-5","article-title":"Hospital readmission for fluid and electrolyte abnormalities following ileostomy construction: preventable or unpredictable?","volume":"17","author":"Hayden","year":"2013","journal-title":"J Gastrointest Surg"},{"issue":"9","key":"10.1016\/j.clcc.2023.01.005_bib0007","doi-asserted-by":"crossref","first-page":"e1555","DOI":"10.1002\/onco.13824","article-title":"Total neoadjuvant therapy (TNT) versus standard neoadjuvant chemoradiotherapy for locally advanced rectal cancer: a systematic review and meta-analysis","volume":"26","author":"Liu","year":"2021","journal-title":"Oncologist"},{"issue":"3","key":"10.1016\/j.clcc.2023.01.005_bib0008","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1097\/SLA.0000000000003471","article-title":"Total neoadjuvant therapy in rectal cancer: a systematic review and meta-analysis of treatment outcomes","volume":"271","author":"Petrelli","year":"2020","journal-title":"Ann Surg"},{"issue":"2","key":"10.1016\/j.clcc.2023.01.005_bib0009","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1136\/jclinpath-2018-205595","article-title":"Neoadjuvant chemoradiation in locally advanced rectal cancer: the surgeon's perspective","volume":"72","author":"Azin","year":"2019","journal-title":"J Clin Pathol"},{"issue":"5","key":"10.1016\/j.clcc.2023.01.005_bib0010","first-page":"459","article-title":"Total neoadjuvant therapy for rectal cancer","volume":"22","author":"Goodman","year":"2018","journal-title":"Cancer Radiother J la Soc Fr Radiother Oncol"},{"issue":"4","key":"10.1016\/j.clcc.2023.01.005_bib0011","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1002\/ags3.12349","article-title":"Challenges and shifting treatment strategies in the surgical treatment of locally advanced rectal cancer","volume":"4","author":"Kim","year":"2020","journal-title":"Ann Gastroenterol Surg"},{"issue":"2","key":"10.1016\/j.clcc.2023.01.005_bib0012","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.clon.2015.11.003","article-title":"Neoadjuvant treatment strategies for locally advanced rectal cancer","volume":"28","author":"Gollins","year":"2016","journal-title":"Clin Oncol (R Coll Radiol)"},{"issue":"23","key":"10.1016\/j.clcc.2023.01.005_bib0013","doi-asserted-by":"crossref","first-page":"2515","DOI":"10.1200\/JCO.22.00506","article-title":"Total neoadjuvant therapy for locally advanced rectal cancer: induction or consolidation chemotherapy?","volume":"40","author":"Aref","year":"2022","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.clcc.2023.01.005_bib0014","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S1470-2045(20)30555-6","article-title":"Short-course radiotherapy followed by chemotherapy before total mesorectal excision (TME) versus preoperative chemoradiotherapy, TME, and optional adjuvant chemotherapy in locally advanced rectal cancer (RAPIDO): a randomised, open-label, phase 3 trial","volume":"22","author":"Bahadoer","year":"2021","journal-title":"Lancet Oncol"},{"issue":"5","key":"10.1016\/j.clcc.2023.01.005_bib0015","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/S1470-2045(21)00079-6","article-title":"Neoadjuvant chemotherapy with FOLFIRINOX and preoperative chemoradiotherapy for patients with locally advanced rectal cancer (UNICANCER-PRODIGE 23): a multicentre, randomised, open-label, phase 3 trial","volume":"22","author":"Conroy","year":"2021","journal-title":"Lancet Oncol"},{"issue":"15","key":"10.1016\/j.clcc.2023.01.005_bib0016","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1200\/JCO.21.01667","article-title":"Multicenter, randomized, phase III trial of short-term radiotherapy plus chemotherapy versus long-term chemoradiotherapy in locally advanced rectal cancer (STELLAR)","volume":"40","author":"Jin","year":"2022","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clcc.2023.01.005_bib0017","unstructured":"Benson AB, Venook AP, Al-Hawaray M. Rectal cancer. NCCN Guidel. 2022."},{"issue":"6","key":"10.1016\/j.clcc.2023.01.005_bib0018","doi-asserted-by":"crossref","DOI":"10.1001\/jamaoncol.2018.0071","article-title":"Adoption of total neoadjuvant therapy for locally advanced rectal cancer","volume":"4","author":"Cercek","year":"2018","journal-title":"JAMA Oncol"},{"issue":"1","key":"10.1016\/j.clcc.2023.01.005_bib0019","doi-asserted-by":"crossref","first-page":"e51","DOI":"10.1016\/j.prro.2016.08.010","article-title":"Preoperative short-course radiation therapy for rectal cancer provides excellent disease control and toxicity: results from a single US institution","volume":"7","author":"Roy","year":"2017","journal-title":"Pract Radiat Oncol"},{"issue":"3","key":"10.1016\/j.clcc.2023.01.005_bib0020","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/j.ijrobp.2021.10.004","article-title":"Clinical complete response in patients with rectal adenocarcinoma treated with short-course radiation therapy and nonoperative management","volume":"112","author":"Chin","year":"2022","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"10","key":"10.1016\/j.clcc.2023.01.005_bib0021","doi-asserted-by":"crossref","first-page":"857","DOI":"10.4251\/wjgo.v11.i10.857","article-title":"Retrospective review of total neoadjuvant therapy","volume":"11","author":"Babar","year":"2019","journal-title":"World J Gastrointest Oncol"},{"issue":"10","key":"10.1016\/j.clcc.2023.01.005_bib0022","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1001\/jamaoncol.2022.2831","article-title":"Patterns of practice and improvements in survival among patients with stage 2\/3 rectal cancer treated with trimodality therapy","volume":"8","author":"Kennecke","year":"2022","journal-title":"JAMA Oncol"},{"issue":"6","key":"10.1016\/j.clcc.2023.01.005_bib0023","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.4251\/wjgo.v14.i6.1148","article-title":"Contemporary, national patterns of surgery after preoperative therapy for stage II\/III rectal adenocarcinoma","volume":"14","author":"Soriano","year":"2022","journal-title":"World J Gastrointest Oncol"},{"issue":"1","key":"10.1016\/j.clcc.2023.01.005_bib0024","doi-asserted-by":"crossref","first-page":"E179","DOI":"10.1016\/j.ijrobp.2019.06.2074","article-title":"A retrospective analysis comparing outcomes following total neoadjuvant therapy and following neoadjuvant chemoradiation therapy in patients with locally advanced rectal cancer","volume":"105","author":"Zhu","year":"2019","journal-title":"Int J Radiat Oncol"},{"key":"10.1016\/j.clcc.2023.01.005_bib0025","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s11605-022-05463-1","article-title":"Total neoadjuvant therapy is a predictor for complete pathological response in patients undergoing surgery for rectal cancer","volume":"26","author":"Horesh","year":"2022","journal-title":"J Gastrointest Surg"},{"issue":"5","key":"10.1016\/j.clcc.2023.01.005_bib0026","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1016\/j.surg.2022.02.006","article-title":"The effect of the first year of the COVID-19 pandemic on sphincter preserving surgery for rectal cancer: A single referral center experience","volume":"171","author":"Freund","year":"2022","journal-title":"Surgery"},{"issue":"3","key":"10.1016\/j.clcc.2023.01.005_bib0027","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1038\/sj.bjc.6602960","article-title":"Neoadjuvant chemotherapy prior to preoperative chemoradiation or radiation in rectal cancer: should we be more cautious?","volume":"94","author":"Glynne-Jones","year":"2006","journal-title":"Br J Cancer"},{"issue":"34","key":"10.1016\/j.clcc.2023.01.005_bib0028","doi-asserted-by":"crossref","first-page":"3212","DOI":"10.1200\/JCO.19.00308","article-title":"Randomized phase II trial of chemoradiotherapy plus induction or consolidation chemotherapy as total neoadjuvant therapy for locally advanced rectal cancer: CAO\/ArO\/AIO-12","volume":"37","author":"Fokas","year":"2019","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.clcc.2023.01.005_bib0029","doi-asserted-by":"crossref","DOI":"10.1001\/jamaoncol.2021.5445","article-title":"Chemoradiotherapy plus induction or consolidation chemotherapy as total neoadjuvant therapy for patients with locally advanced rectal cancer: long-term results of the CAO\/ARO\/AIO-12 randomized clinical trial","volume":"8","author":"Fokas","year":"2022","journal-title":"JAMA Oncol"},{"issue":"23","key":"10.1016\/j.clcc.2023.01.005_bib0030","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.22.00032","article-title":"Organ preservation in patients with rectal adenocarcinoma treated with total neoadjuvant therapy","volume":"18","author":"Garcia-Aguilar","year":"2022","journal-title":"J Clin Oncol"},{"issue":"4","key":"10.1016\/j.clcc.2023.01.005_bib0031","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.adro.2018.07.007","article-title":"Utilization of short-course radiation therapy for patients with nonmetastatic rectal adenocarcinoma in the United States","volume":"3","author":"Abdel-Rahman","year":"2018","journal-title":"Adv Radiat Oncol"},{"issue":"8","key":"10.1016\/j.clcc.2023.01.005_bib0032","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1002\/cncr.30461","article-title":"Neoadjuvant long-course chemoradiation remains strongly favored over short-course radiotherapy by radiation oncologists in the United States","volume":"123","author":"Mowery","year":"2017","journal-title":"Cancer"},{"issue":"3","key":"10.1016\/j.clcc.2023.01.005_bib0033","doi-asserted-by":"crossref","first-page":"e341","DOI":"10.1016\/j.ijrobp.2021.07.1031","article-title":"Healthcare cost analysis of short-course vs. long-course pre-operative radiotherapy schedules for rectal cancer","volume":"111","author":"Dalwadi","year":"2021","journal-title":"Int J Radiat Oncol"},{"issue":"4","key":"10.1016\/j.clcc.2023.01.005_bib0034","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/j.adro.2020.04.011","article-title":"Management of locally advanced rectal cancer during the COVID-19 pandemic: a necessary paradigm change at Memorial Sloan Kettering Cancer Center","volume":"5","author":"Romesser","year":"2020","journal-title":"Adv Radiat Oncol"},{"issue":"3","key":"10.1016\/j.clcc.2023.01.005_bib0035","first-page":"39","article-title":"The evolving landscape of neoadjuvant radiation therapy for locally advanced rectal cancer","volume":"16","author":"Yoon","year":"2020","journal-title":"Curr Colorectal Cancer Rep"},{"issue":"1","key":"10.1016\/j.clcc.2023.01.005_bib0036","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.jgo.2012.10.173","article-title":"Disparity in the use of combined modality therapy for rectal cancer in the older adult","volume":"4","author":"Bohac","year":"2013","journal-title":"J Geriatr Oncol"},{"issue":"2","key":"10.1016\/j.clcc.2023.01.005_bib0037","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1001\/archsurg.139.2.151","article-title":"Racial disparities in rectal cancer treatment: a population-based analysis","volume":"139","author":"Morris","year":"2004","journal-title":"Arch Surg"},{"issue":"3","key":"10.1016\/j.clcc.2023.01.005_bib0038","first-page":"178","article-title":"Racial Differences in stage IV colorectal cancer survival in younger and older patients","volume":"16","author":"Wallace","year":"2017","journal-title":"Clin Colorectal Cancer"},{"issue":"Suppl 1","key":"10.1016\/j.clcc.2023.01.005_bib0039","first-page":"S32","article-title":"Health disparities in colorectal cancer among racial and ethnic minorities in the United States","volume":"7","author":"Jackson","year":"2016","journal-title":"J Gastrointest Oncol"},{"issue":"10","key":"10.1016\/j.clcc.2023.01.005_bib0040","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1200\/JCO.2004.08.173","article-title":"Impact of T and N stage and treatment on survival and relapse in adjuvant rectal cancer: a pooled analysis","volume":"22","author":"Gunderson","year":"2004","journal-title":"J Clin Oncol"},{"issue":"8","key":"10.1016\/j.clcc.2023.01.005_bib0041","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1093\/annonc\/mdv223","article-title":"Chemoradiation, surgery and adjuvant chemotherapy versus induction chemotherapy followed by chemoradiation and surgery: long-term results of the Spanish GCR-3 phase II randomized trial\u2020","volume":"26","author":"Fernandez-Martos","year":"2015","journal-title":"Ann Oncol"},{"issue":"4","key":"10.1016\/j.clcc.2023.01.005_bib0042","first-page":"1","article-title":"Current practice patterns in locally advanced rectal cancer at academic institutions: a national survey among radiation oncologists, medical oncologists, and colorectal surgeons","volume":"21","author":"Wu","year":"2022","journal-title":"Clin Colorectal Cancer"}],"container-title":["Clinical Colorectal Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S153300282300004X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S153300282300004X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T23:07:57Z","timestamp":1761520077000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S153300282300004X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":42,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["S153300282300004X"],"URL":"https:\/\/doi.org\/10.1016\/j.clcc.2023.01.005","relation":{},"ISSN":["1533-0028"],"issn-type":[{"type":"print","value":"1533-0028"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Patterns of Care for Patients With Locally Advanced Rectal Cancer Treated with Total Neoadjuvant Therapy at Predominately Academic Centers between 2016-2020: An NCDB Analysis","name":"articletitle","label":"Article Title"},{"value":"Clinical Colorectal Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clcc.2023.01.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}